These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35047245)

  • 1. Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer.
    Matsunaga S; Shuto T
    Cureus; 2021 Dec; 13(12):e20398. PubMed ID: 35047245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma Knife radiosurgery for metastatic brain tumors from ovarian cancer: histopathological analysis of survival and local control. A Japanese multi-institutional cooperative and retrospective cohort study.
    Matsunaga S; Shuto T; Serizawa T; Aoyagi K; Hasegawa T; Kawagishi J; Yomo S; Kenai H; Nakazaki K; Moriki A; Iwai Y; Yamamoto T
    J Neurosurg; 2022 Oct; 137(4):1006-1014. PubMed ID: 35148503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non-small cell lung cancer and brain metastases.
    Lee CC; Hsu SPC; Lin CJ; Wu HM; Chen YW; Luo YH; Chiang CL; Hu YS; Chung WY; Shiau CY; Guo WY; Hung-Chi Pan D; Yang HC
    J Neurosurg; 2020 Aug; 133(2):313-320. PubMed ID: 31226692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
    Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
    J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?
    Wang TJ; Saad S; Qureshi YH; Jani A; Nanda T; Yaeh AM; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Lesser J; Halmos B; Stoopler MB; Lassman AB; Cheng SK; Isaacson SR
    Neuro Oncol; 2015 Jul; 17(7):1022-8. PubMed ID: 25910841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases.
    Liao HR; Chiang CL; Shen CI; Chen CJ; Yang HC; Wu HM; Luo YH; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Pan DH; Lee CC
    J Neurooncol; 2022 Sep; 159(3):675-684. PubMed ID: 35976545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
    Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
    J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
    Balasubramanian SK; Sharma M; Venur VA; Schmitt P; Kotecha R; Chao ST; Suh JH; Angelov L; Mohammadi AM; Vogelbaum MA; Barnett GH; Jia X; Pennell NA; Ahluwalia MS
    Neuro Oncol; 2020 Feb; 22(2):267-277. PubMed ID: 31648302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Cancer of Unknown Primary.
    Matsunaga S; Shuto T; Kobayashi N
    World Neurosurg; 2019 Feb; 122():e1465-e1471. PubMed ID: 30468925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery.
    Lee MH; Kong DS; Seol HJ; Nam DH; Lee JI
    J Korean Neurosurg Soc; 2017 Jan; 60(1):21-29. PubMed ID: 28061489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Epidermal Growth Factor Receptor Mutation on Intracranial Progression-Free Survival of Non-Small Cell Lung Cancer Patients with Brain Metastasis Underwent Gamma Knife Radiosurgery.
    Yang SH; Kim HY; Lee SI; Jin SJ
    Brain Tumor Res Treat; 2020 Oct; 8(2):103-108. PubMed ID: 33118342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501).
    Matsunaga S; Shuto T; Yamamoto M; Yomo S; Kondoh T; Kobayashi T; Sato M; Okamoto H; Serizawa T; Nagano O; Kenai H; Obara T; Iwai Y; Yasuda S; Hasegawa T; Kubo K; Shidoh S; Mori K; Hayashi M; Inoue A; Onoue S; Gondo M
    Stereotact Funct Neurosurg; 2018; 96(3):162-171. PubMed ID: 29969770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.
    Ge Y; Liu D; Zhang Z; Li Y; Lin Y; Wang G; Zong Y; Liu E
    Neurosurg Focus; 2019 Jun; 46(6):E7. PubMed ID: 31153153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome in gamma knife radiosurgery for metastatic brain tumors from the primary breast cancer : prognostic factors in local treatment failure and survival.
    Choi SW; Kwon DH; Kim CJ
    J Korean Neurosurg Soc; 2013 Oct; 54(4):329-35. PubMed ID: 24294457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].
    Lin YP; Li Q; Ma LY; Liu X; Dai M; Wang XX; Li HS; Liu JX; Shen ZH; Guo YJ; Du YX; Yang RJ; Huang YC; Zhou YC
    Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):735-740. PubMed ID: 32988155
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer.
    Na YC; Jung HH; Kim HR; Cho BC; Chang JW; Park YG; Chang WS
    J Neurooncol; 2017 Apr; 132(2):333-340. PubMed ID: 28074321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Uterine Cervical and Endometrial Carcinomas: Histopathological Analysis of Survival and Local Control. A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study.
    Matsunaga S; Shuto T; Serizawa T; Aoyagi K; Hasegawa T; Kawagishi J; Yomo S; Kenai H; Nakazaki K; Moriki A; Iwai Y; Yamanaka K; Yamamoto T
    World Neurosurg; 2023 Mar; 171():e572-e580. PubMed ID: 36529429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Suh JH; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Chao ST
    Pract Radiat Oncol; 2017; 7(4):e263-e273. PubMed ID: 28254368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Single-Institution Analysis of 126 Patients Treated with Stereotactic Radiosurgery for Brain Metastases.
    Harris KB; Corbett MR; Mascarenhas H; Lee KS; Arastu H; Leinweber C; Ju AW
    Front Oncol; 2017; 7():90. PubMed ID: 28553615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.